Literature DB >> 23364796

The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production.

María Rosa López-Huertas1, Elena Mateos, María Sánchez Del Cojo, Francisco Gómez-Esquer, Gema Díaz-Gil, Sara Rodríguez-Mora, Juan Antonio López, Enrique Calvo, Guillermo López-Campos, José Alcamí, Mayte Coiras.   

Abstract

HIV-1 replication is efficiently controlled by the regulator protein Tat (101 amino acids) and codified by two exons, although the first exon (1-72 amino acids) is sufficient for this process. Tat can be released to the extracellular medium, acting as a soluble pro-apoptotic factor in neighboring cells. However, HIV-1-infected CD4(+) T lymphocytes show a higher resistance to apoptosis. We observed that the intracellular expression of Tat delayed FasL-mediated apoptosis in both peripheral blood lymphocytes and Jurkat cells, as it is an essential pathway to control T cell homeostasis during immune activation. Jurkat-Tat cells showed impairment in the activation of caspase-8, deficient release of mitochondrial cytochrome c, and delayed activation of both caspase-9 and -3. This protection was due to a profound deregulation of proteins that stabilized the mitochondrial membrane integrity, such as heat shock proteins, prohibitin, or nucleophosmin, as well as to the up-regulation of NF-κB-dependent anti-apoptotic proteins, such as BCL2, c-FLIPS, XIAP, and C-IAP2. These effects were observed in Jurkat expressing full-length Tat (Jurkat-Tat101) but not in Jurkat expressing the first exon of Tat (Jurkat-Tat72), proving that the second exon, and particularly the NF-κB-related motif ESKKKVE, was necessary for Tat-mediated protection against FasL apoptosis. Accordingly, the protection exerted by Tat was independent of its function as a regulator of both viral transcription and elongation. Moreover, these data proved that HIV-1 could have developed strategies to delay FasL-mediated apoptosis in infected CD4(+) T lymphocytes through the expression of Tat, thus favoring the persistent replication of HIV-1 in infected T cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23364796      PMCID: PMC3597804          DOI: 10.1074/jbc.M112.408294

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  113 in total

1.  Nucleolar protein B23 has molecular chaperone activities.

Authors:  A Szebeni; M O Olson
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.

Authors:  S H Pincus; K G Messer; P L Nara; W A Blattner; G Colclough; M Reitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 3.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

4.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

5.  Mitochondrial release of pro-apoptotic proteins: electrostatic interactions can hold cytochrome c but not Smac/DIABLO to mitochondrial membranes.

Authors:  Rachel T Uren; Grant Dewson; Christine Bonzon; Trevor Lithgow; Donald D Newmeyer; Ruth M Kluck
Journal:  J Biol Chem       Date:  2004-11-09       Impact factor: 5.157

6.  Mammalian HSP60 is quickly sorted into the mitochondria under conditions of dehydration.

Authors:  Hideaki Itoh; Atsushi Komatsuda; Hiroshi Ohtani; Hideki Wakui; Hirokazu Imai; Ken-Ichi Sawada; Michiro Otaka; Masahito Ogura; Akira Suzuki; Fumio Hamada
Journal:  Eur J Biochem       Date:  2002-12

7.  An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection.

Authors:  Stephen M Smith; Sara Pentlicky; Zachary Klase; Mahender Singh; Christine Neuveut; Chun-yi Lu; Marvin S Reitz; Robert Yarchoan; Preston A Marx; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

8.  Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement.

Authors:  M Jones; K Olafson; M R Del Bigio; J Peeling; A Nath
Journal:  J Neuropathol Exp Neurol       Date:  1998-06       Impact factor: 3.685

9.  Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.

Authors:  S Desagher; A Osen-Sand; A Nichols; R Eskes; S Montessuit; S Lauper; K Maundrell; B Antonsson; J C Martinou
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

10.  Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway.

Authors:  Pablo N Fernández Larrosa; Diego O Croci; Diego A Riva; Mariel Bibini; Renata Luzzi; Mónica Saracco; Susana E Mersich; Gabriel A Rabinovich; Liliana Martínez Peralta
Journal:  Retrovirology       Date:  2008-02-08       Impact factor: 4.602

View more
  28 in total

Review 1.  Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter.

Authors:  Anthony R Mele; Jamie Marino; Kenneth Chen; Vanessa Pirrone; Chris Janetopoulos; Brian Wigdahl; Zachary Klase; Michael R Nonnemacher
Journal:  Traffic       Date:  2018-04-30       Impact factor: 6.215

2.  Structural and Functional Study of Apoptosis-linked Gene-2·Heme-binding Protein 2 Interactions in HIV-1 Production.

Authors:  Jing Ma; Xianfeng Zhang; Yanbin Feng; Hui Zhang; Xiaojun Wang; Yonghui Zheng; Wentao Qiao; Xinqi Liu
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

3.  SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells.

Authors:  Grant R Campbell; Rachel S Bruckman; Yen-Lin Chu; Rodney N Trout; Stephen A Spector
Journal:  Cell Host Microbe       Date:  2018-10-18       Impact factor: 21.023

Review 4.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

Review 5.  The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence.

Authors:  Aswath P Chandrasekar; Nathan W Cummins; Andrew D Badley
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

Review 6.  Proteomics in the investigation of HIV-1 interactions with host proteins.

Authors:  Ming Li
Journal:  Proteomics Clin Appl       Date:  2015-01-19       Impact factor: 3.494

7.  Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.

Authors:  Robert W Link; Anthony R Mele; Gregory C Antell; Vanessa Pirrone; Wen Zhong; Katherine Kercher; Shendra Passic; Zsofia Szep; Kim Malone; Jeffrey M Jacobson; Will Dampier; Brian Wigdahl; Michael R Nonnemacher
Journal:  Virus Res       Date:  2019-08-19       Impact factor: 3.303

8.  Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.

Authors:  Nathan W Cummins; Amy M Sainski; Haiming Dai; Sekar Natesampillai; Yuan-Ping Pang; Gary D Bren; Maria Cristina Miranda de Araujo Correia; Rahul Sampath; Stacey A Rizza; Daniel O'Brien; Joseph D Yao; Scott H Kaufmann; Andrew D Badley
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 9.  Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death.

Authors:  Ana C Paim; Andrew D Badley; Nathan W Cummins
Journal:  AIDS Res Hum Retroviruses       Date:  2019-12-10       Impact factor: 2.205

Review 10.  Altering cell death pathways as an approach to cure HIV infection.

Authors:  A D Badley; A Sainski; F Wightman; S R Lewin
Journal:  Cell Death Dis       Date:  2013-07-11       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.